Home Recalls D-0432-2021
Class II · Moderate risk Terminated Initiated Mar 15, 2021 (5 years ago)
Gemcitabine Injection 200mg/5.26ml; Ndc/Upc 72485-221-02; Rx; Singledose Vial
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
What was recalled
GEMCITABINE INJECTION 200MG/5.26ML; NDC/UPC 72485-221-02; RX; SINGLEDOSE VIAL
Recalling firm Cardinal Health Inc.
Origin OH, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0432-2021
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jun 10, 2026
Reason Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
Class II · Moderate risk Terminated Dec 6, 2021
Reason Lack of Assurance of Sterility
Class II · Moderate risk Terminated Jun 12, 2019
Reason Lack of Assurance of Sterility
Class I · High risk Terminated Mar 23, 2015
Reason Presence of Particulate Matter
Class I · High risk Terminated Mar 23, 2015
Reason Presence of Particulate Matter